Re: Trading
in response to
by
...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Message: Re: Trading
The Cease Trade order was put in place on Sept. 7 and as KOO posted, the filing was done on Sept. 15 to return them to good standing. Below shows no active orders and shows the recent one as revoked on Sept. 20 so all is cleared up.
| Click the Issued Date to view the cease trade order. Company: Zenith Capital Corp. Current Date: |
|
|||
 |
| Issued Date | |
Issuing Jurisdiction(s) | |
Status | |
Expiry Date | |
Exception | |
Type | |
|
Active Cease Trade Orders |
|||||||||||
|
Inactive Cease Trade Orders |
|||||||||||
| 2022/09/20 | |
AB-ON | |
Revoked | |
None | |
No | |
Ban Securities Trading OF | |
|
|||||||||||
| 2022/09/07 | |
AB-ON | |
Issued | |
None | |
No | |
Ban Securities Trading OF | |
|
|||||||||||
| 2020/10/28 | |
AB | |
Revoked | |
None | |
No | |
Ban Securities Trading BY | |
| CANN, Brad; MCCAFFREY, Donald | |||||||||||
|
|||||||||||
| 2020/09/29 | |
AB | |
Issued | |
None | |
No | |
Ban Securities Trading BY | |
| CANN, Brad; MCCAFFREY, Donald |
New Message
Please
login
to post a reply